Thomas Malone, 48, of New Haven, was arrested today on federal charges alleging he stole nearly $1 million from the biotech company he was hired to financially safeguard. The CFO of Artificial Cell Technologies, Inc. (ACT), Malone is accused of systematically looting the firm over a four-year span, using company funds for unauthorized salary hikes, personal credit card charges, and political donations he alone backed.
As chief financial officer, Malone managed all financial operations for ACT, a small but ambitious New Haven firm developing advanced vaccine delivery systems for malaria and Respiratory Syncytial Virus. The company has received approximately $4.1 million in federal research grants from the National Institutes of Health since 2008. His duties included handling investor and grant funds, managing payroll, reconciling accounts, and ensuring compliance with federal spending rules—responsibilities he allegedly exploited to enrich himself.
The scheme began unraveling in November 2016 when ACT’s CEO discovered Malone was paying himself roughly $660,000 annually—more than double his authorized salary of $281,000. A deeper dive into financial records revealed a pattern of fraud: checks disguised as bonuses, unapproved salary disbursements, personal use of the corporate credit card, and $950,000 in total embezzled funds between 2012 and 2016. A forensic audit confirmed the losses and exposed the depth of financial manipulation.
Malone appeared before U.S. Magistrate Judge Sarah A. L. Merriam in New Haven and was released on a $50,000 bond. He faces one count of theft from a program receiving federal funds—a charge carrying a maximum sentence of 10 years in prison. Federal prosecutors stress that the complaint is not evidence of guilt, and Malone is presumed innocent until proven guilty beyond a reasonable doubt.
This investigation was led by the U.S. Department of Health and Human Services, Office of Inspector General, and the Federal Bureau of Investigation’s New Haven Division. The case underscores growing scrutiny over misuse of federal research dollars, particularly within small, grant-dependent biotech firms where oversight may be thin and internal controls vulnerable to exploitation.
Assistant U.S. Attorney Douglas P. Morabito is prosecuting the case. As federal watchdogs tighten their grip on grant accountability, the Thomas Malone case serves as a stark warning: even in the high-stakes world of medical innovation, greed can turn gatekeepers into thieves.
Related Federal Cases
- Thomas Recck Embezzled $125K from Canine Rescue Group · Ohio
- Carrie Caesar Indicted for Embezzlement · Connecticut
- Rosemarie Colazzo Sentenced for $700K Embezzlement Scheme · Connecticut
- Rebecca Block Pleads Guilty in $190K Embezzlement Scheme · Connecticut
- Vanessa Vence-Small Admits to $1.1M Embezzlement · New York
Key Facts
- State: Connecticut
- Agency: DOJ USAO
- Category: Fraud & Financial Crimes
- Source: Official Source ↗
🔒 Get the grimiest stories delivered weekly. Subscribe free →
Browse More
